鹿児島大学大学院 医歯学総合研究科 心臓血管・高血圧内科学

Facebook

Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University

研究について

臨床研究:業績

【2015】原著(英文)

  • Soejima Y, Munemoto T, Masuda A, Uwatoko Y, Miyata M, Tei C.
  • Effects of Waon therapy on chronic fatigue syndrome: a pilot study.
    Internal Medicine 2015; 54: 333-338.
  • Ikeda Y, Shirakabe A, Maejima Y, Zhai P, Sciarretta S, Toli J, Nomura M, Mihara K, Egashira K, Ohishi M, Abdellatif M, Sadoshima J.
  • Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress.
    Circ Res 2015; 116: 264-278.
  • Ikeda Y, Shirakabe A, Maejima Y, Zhai P, Sciarretta S, Toli J, Nomura M, Mihara K, Egashira K, Ohishi M, Abdellatif M, Sadoshima J.
  • Molecular mechanisms mediating mitochondrial dynamics and mitophagy and their functional roles in the cardiovascular system.
    J Mol Cell Cardiol 2015; 78: 116-122.
  • Ichiki T, Huntley BK, Sangaralingham SJ, Burnett JC Jr.
  • Pro-atrial natriuretic peptide: a novel guanylyl cyclase-A receptor activator which goes beyond atrial and B-type natriuretic peptide.
    JACC Heart Failure 2015; 3: 715-723.
  • Kajiya T, Low AF, Lee CH, Tan HC, Poh KK.
  • Left main percutaneous coronary intervention improves left ventricular systolic function assessed by tissue Doppler echocardiography.
    Int J Cardiol 2015; 187: 4-6.
  • Nomoto Y, Tsurugida M, Kihara K, Miyauchi E, Kosedo I, Yuasa T, Otsuji Y, Ohishi M.
  • Attenuated early diastolic interventricular septum bulging by pulmonary hypertension due to later developed aortic regurgitation.
    J Echocardiogr 2015; 13: 110-112.
  • Namino F, Iriki Y, Maenosono R, Ichiki H, Okui H, Yoshimura A, Oketani N, Matsushita M, Ohishi M, Hashiguchi T.
  • The optimal setting of complex fractionated atrial electrograms software in substrate ablation for atrial fibrillation.
    J Arrhythm 2015; 31: 6-11.
  • Yamamoto K, Kakino A, Takeshita H, Hayashi N, Li L, Nakano A, Hanasaki-Yamamoto H, Fujita Y, Imaizumi Y, Serina Toyama-Yokoyama S, Nakama C, Kawai T, Takeda M, Hongyo K, Oguro R, Maekawa Y, Itoh N, Takami Y, Onishi M,Takeya Y, Sugimoto K, Kamide K, Nakagami H, Ohishi M, Kurtz TW, Sawamura T, Rakugi H.
  • Oxidized LDL (oxLDL) activates the angiotensin II type 1 receptor (AT1) by binding to the lectin-like oxLDL receptor (LOX-1) .
    FASEB J 2015; 29: 3342-3356.
  • Kawai T, Ohishi M, Onishi M, Ito N, Takeya Y, Oguro R, Takami Y, Yamamoto K, Rakugi H.
  • Prognostic impact of regional arterial stiffness in hypertensive patients.
    Heart Vessels 2015; 30: 338-346.
  • Yamamoto K, Yamamoto H, Takeuchi M, Kisanuki A, Akasaka T, Ohte N, Hirano Y, Yoshida K, Nakatani S, Takeda Y, Sozu T, Masuyama T.
  • Risk factors for progression of degenerative aortic valve disease in the Japanese - The Japanese aortic stenosis study (JASS) prospective analysis.
    Circ J 2015; 79: 2050-2057.
  • Watanabe H, Morimoto T, Natsuaki M, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kastrati A, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators.
  • Antiplatelet therapy discontinuation and the risk of serious cardiovascular events after coronary stenting: observations from the CREDO-Kyoto Registry Cohort-2.
    PLoS One 2015; 10: e0124314.
  • Huntley BK, Sandberg SM, Heublein DM, Sangaralingham SJ, Burnett JC Jr, Ichiki T.
  • ProBNP1-108 processing and degradation in human heart failure.
    Circulaiton: Heart Failure 2015; 8: 89-97.
  • Sangaralingham SJ, McKie PM, Ichiki T, Scott CG, Heublein DM, Chen HH, Bailey KR, Redfield MM, Rodeheffer RJ, Burnett JC Jr.
  • Circulating C-type natriuretic peptide and its relationship to cardiovascular disease in the general population. Relationship between vascular endothelial growth factor and left ventricular dimension in patients with acute myocardial infarction.
    Hypertension 2015; 65: 1187-1194.
  • Haseba S, Sakakima H, Kubozono T, Nakao S, Ikeda S.
  • Combined effects of repeated sauna therapy and exercise training on cardiac function and physical activity in patients with chronic heart failure.
    Disabil Rehabil 2015; 20: 1-7.
  • Cheng KK, Akasaki Y, Lecommandeur E, Lindsay RT, Murfitt S, Walsh K, Griffin JL.
  • Metabolomic analysis of Akt1-mediated muscle hypertrophy in models of diet-induced obesity and age-related fat accumulation.
    J Proteome Res 2015; 14: 342-352.
  • Nagai T, Furusho Y, Li H, Hasui K, Matsukita S, Sueyoshi K, Yanagi M, Hatae M, Takao S, Matsuyama T.
  • Production of a high-affinity monoclonal antibody reactive with folate receptors alpha and beta.
    Monoclon Antib Immunodiagn Immunother 2015; 34: 181-90.
  • Liang M, Kajiya T, Chan MY, Tay E, Lee CH, Richards AM, Low AF, Tan HC.
  • High grade culprit lesions are a common cause of ST-segment elevation myocardial infarction.
    Singapore Med J 2015; 56: 334-338.
  • Hirano M, Satake W, Ihara K, Tsuge I, Kondo S, Saida K, Betsui H, Okubo K, Sakamoto H, Ueno S, Ikuno Y, Ishihara R, Iwahashi H, Ohishi M, Mano T, Yamashita T, Suzuki Y, Nakamura Y, Kusunoki S, Toda T.
  • The first nationwide survey and genetic analyses of Bardet-Biedl syndrome in Japan.
    PLoS One 2015; 10: e0136317.
  • Yoshino S, Cilluffo R, Prasad M, Best PJ, Atkinson E, Aoki T, Cunningham J, Andrade M, Lerman L, Lerman A.
  • Sex-specific genetic variants are associated with coronary endothelial dysfunction.
    J Am Heart Assoc 2015 (in press)
  • Kanda D, Takumi T, Miyata M, Tokushige A, Sonoda T, Yoshino S, Saihara K, Ohishi M.
  • Angiotensin-converting enzyme inhibitor prevents the worsening of renal function in the late phase after percutaneous coronary intervention.
    J Atheroscler Thromb 2015 (in press)
  • Ohno S, Miyata M, Kohjitani A, Tohya A, Ohishi M, Sugiyama K.
  • Associations between blood pressure responses to acute stress and impaired renal function and serum uric acid level.
    Clin Exp Hypertens 2015 (in press)
  • Maekawa Y, Sugimoto K, Yamazaki M, Takeya Y, Yamamoto K, Ohishi M, Ogihara T, Shintani A, Doki Y, Mori M, Rakugi H.
  • Comprehensive geriatric assessment (CGA) is a useful predictive tool for understanding the development of postoperative delirium (POD) after gastrointestinal surgery in old-old adults.
    Geriat Gerontol Int 2015 (in press)
  • Daitoku S, Yuasa T, Tsunenari H, Maenohara S, Mine K, Tamatsu Y, Shimada K, Koriyama C, Ohishi M, Horiuchi M.
  • Angle between the common and internal carotid arteries detected by ultrasound is related to intima-media thickness among those with atherosclerotic disease.
    Environ Health Prev Med 2015 (in press)
  • Arima R, Yamaguchi H, Takaoka J, Miyamura A, Atsuchi N, Ninomiya T, Atsuchi Y, Ohishi M, Terashima M, Kaneda H.
  • Simple balloon dilation for drug-eluting in-stent restenosis:an optical coherent tomography Analysis.
    Cardiovasc Revasc Med 2015 (in press)
  • Yamaguchi H, Arikawa R, Takaoka J, Miyamura A, Atsuchi N, Ninomiya T, Atsuchi Y, Ohishi M, Terashima M, Kaneda H.
  • Association of morphologic characteristics on optical coherence tomography and angiographic progression patterns of late restenosis after drug-eluting stent implantation.
    Cardiovasc Revasc Med 2015 (in press)
  • Tokito A, Koriyama N, Ijuin A, Ogiso K, Nishio Y, Jougasaki M.
  • Switching from sitagliptin to alogliptin under treatment with pioglitazone increases high-molecular weight adiponectin in type 2 diabetes: a prospective observational study.
    J Diabetes Mellitus 2015 (in press)
  • Kyrychenko S, Kyrychenko V, Badr MA, Ikeda Y, Sadoshima J, Shirokova N.
  • Pivotal role of miR-448 in the development of ROS-induced cardiomyopathy.
    Cardiovasc Res 2015 (in press).
  • Oka SI, Zhai P, Yamamoto T, Ikeda Y, Byun J, Hsu CP, Sadoshima J.
  • PPARα association with sirt1 suppresses cardiac fatty acid metabolism in the failing heart.
    Circ Heart Fail 2015 (in press).
  • Lee CYW, Huntley BK, McCormick DJ, Ichiki T, Sangaralingham SJ, Lisy O, Burnett JC Jr.
  • Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.
    Eur Heart J - Cardiovasc Pharmacotherapy 2015 (in press).
  • 昨年度追加分
  • Ikeda Y, Sciarretta S, Nagarajan N, Rubattu S, Volpe M, Frati G, Sadoshima J.
  • New insights into the role of mitochondrial dynamics and autophagy during oxidative stress and aging in the heart.
    Oxid Med Cell Longev 2014; 2014: 210934.
  • Kajiya T, Tan HC, Low AF.
  • Successful slender percutaneous coronary intervention (PCI) with ABSORB bioresorbable vascular scaffold (BVS).
    Int J Cardiol 2014; 177: e63-64.
  • Maemura R, Kajiya T, Koriyama N, Lee S.
  • Heart failure caused by atrial fibrillation in a patient with isolated adrenocorticotropic hormone (ACTH) deficiency and Hashimoto's thyroiditis.
    Heart Views 2014; 15: 129-132.